Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin

BACKGROUND: SGLT2 (sodium/glucose cotransporter 2) inhibitors exert robust cardioprotective effects against heart failure in patients with diabetes, and there is intense interest to identify the underlying molecular mechanisms that afford this protection. Because the induction of the late component...

Descripción completa

Detalles Bibliográficos
Autores principales: Philippaert, Koenraad, Kalyaanamoorthy, Subha, Fatehi, Mohammad, Long, Wentong, Soni, Shubham, Byrne, Nikole J., Barr, Amy, Singh, Jyoti, Wong, Jordan, Palechuk, Taylor, Schneider, Chloe, Darwesh, Ahmed M., Maayah, Zaid H., Seubert, John M., Barakat, Khaled, Dyck, Jason R.B., Light, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154177/
https://www.ncbi.nlm.nih.gov/pubmed/33832341
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.053350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154177/
https://www.ncbi.nlm.nih.gov/pubmed/33832341
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.053350

Ejemplares similares